| Announce Date | 08/27/2025 |
| EPS Normalized Actual | $1.37 In Line |
| EPS GAAP Actual | $1.37 In Line |
| Revenue Actual | $1.738B |
| Revenue Surprise | Beat by $1738M |
| Announce Date | 10/30/2025 (Pre-Market) |
| EPS Normalized Estimate | $1.71698 |
| EPS GAAP Estimate | $1.71698 |
| Revenue Estimate | $1.91094424B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Oct 2029 | 7.63 | 19.08 | 7.54677 | 7.71988 | 1 |
| Oct 2028 | 7.59 | 19.18 | 7.45627 | 7.78845 | 4 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Jul 2025) | 1.18 | -0.41373 | 1.738B | 9.21% | -55.5M |
| FQ2 2025 (Apr 2025) | 0.75 | 0.75 | 1.668B | 5.7% | 1668M |
| FQ1 2025 (Jan 2025) | 1.12 | 1.12 | 1.681B | 1.37% | 1681M |
| FQ4 2024 (Oct 2024) | 1.23 | 1.23 | 1.701B | 0.76% | 1701M |
| FQ3 2024 (Jul 2024) | 0.97 | 0.97 | 1.578B | -5.96% | 1578M |
| FQ2 2024 (Apr 2024) | 1.05 | 1.05 | 1.573B | -9.15% | 1573M |
| FQ1 2024 (Jan 2024) | 1.18 | 1.18 | 1.658B | -5.91% | 1658M |
| FQ4 2023 (Oct 2023) | 1.63 | 1.63 | 1.688B | -9.54% | 1688M |
FQ4 Announce Date
10/30/2025 (Pre-Market)
Consensus EPS Estimates
1.71698
Consensus Revenue Estimates
1.91094424B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Oct 2027) | 1.98397 | -- | 1.97056 | 2.00223 | 8 |
| FQ3 2027 (Jul 2027) | 1.6625 | -- | 1.65126 | 1.6778 | 14 |
| FQ2 2027 (Apr 2027) | 1.58394 | -- | 1.56583 | 1.59663 | 5 |
| FQ1 2027 (Jan 2027) | 1.53325 | -- | 1.52644 | 1.5468 | 7 |
| FQ4 2026 (Oct 2026) | 1.92167 | -- | 1.89025 | 1.94524 | 4 |
| FQ3 2026 (Jul 2026) | 1.70202 | 30.67 | 1.67419 | 1.72289 | 4 |
| FQ2 2026 (Apr 2026) | 1.51907 | 50.63 | 1.49423 | 1.5377 | 4 |
| FQ1 2026 (Jan 2026) | 1.56528 | 28.45 | 1.46448 | 1.59715 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Oct 2027) | 1.99B | -- | 1.98B | 2.01B | 7 |
| FQ3 2027 (Jul 2027) | 1.84B | -- | 1.83B | 1.86B | 7 |
| FQ2 2027 (Apr 2027) | 1.87B | -- | 1.86B | 1.89B | 6 |
| FQ1 2027 (Jan 2027) | 1.86B | -- | 1.85B | 1.87B | 7 |
| FQ4 2026 (Oct 2026) | 2.08B | -- | 2.05B | 2.1B | 5 |
| FQ3 2026 (Jul 2026) | 1.94B | 10.6 | 1.92B | 1.96B | 4 |
| FQ2 2026 (Apr 2026) | 1.83B | 9.03 | 1.81B | 1.85B | 8 |
| FQ1 2026 (Jan 2026) | 1.83B | 8.03 | 1.74B | 1.86B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Jul 2025) | 1.59373 | 1.18 | -0.41373 | -35.06% |
| FQ2 2025 (Apr 2025) | 0.75 | 0.75 | 100% | |
| FQ1 2025 (Jan 2025) | 1.12 | 1.12 | 100% | |
| FQ4 2024 (Oct 2024) | 1.23 | 1.23 | 100% | |
| FQ3 2024 (Jul 2024) | 0.97 | 0.97 | 100% | |
| FQ2 2024 (Apr 2024) | 1.05 | 1.05 | 100% | |
| FQ1 2024 (Jan 2024) | 1.18 | 1.18 | 100% | |
| FQ4 2023 (Oct 2023) | 1.63 | 1.63 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Jul 2025) | $1.79B | $1.74B | $-55.5M | -3.19% |
| FQ2 2025 (Apr 2025) | $0B | $1.67B | $1668M | 100% |
| FQ1 2025 (Jan 2025) | $0B | $1.68B | $1681M | 100% |
| FQ4 2024 (Oct 2024) | $0B | $1.7B | $1701M | 100% |
| FQ3 2024 (Jul 2024) | $0B | $1.58B | $1578M | 100% |
| FQ2 2024 (Apr 2024) | $0B | $1.57B | $1573M | 100% |
| FQ1 2024 (Jan 2024) | $0B | $1.66B | $1658M | 100% |
| FQ4 2023 (Oct 2023) | $0B | $1.69B | $1688M | 100% |